| Literature DB >> 30443265 |
Gaetano Antonio Lanza1, Antonio De Vita1, Juan-Carlos Kaski2.
Abstract
Microvascular angina (MVA), i.e. angina caused by abnormalities of the coronary microcirculation, is increasingly recognised in clinical practice. The pathogenetic mechanisms of MVA are heterogeneous and may involve both structural and functional alterations of coronary microcirculation, and functional abnormalities may variably involve an impairment of coronary microvascular dilatation and an increased microvascular constrictor activity. Both invasive and non-invasive diagnostic tools exist to identify patients with MVA in clinical practice. Prognosis has been reported to be good in primary MVA patients, although the prognostic implications of coronary microvascular dysfunction (CMVD) in more heterogeneous populations of angina patients need further assessment. Management of primary MVA can be challenging, but pharmacological and non-pharmacological treatments exist that allow satisfactory control of symptoms in most patients.Entities:
Keywords: Microvascular angina; angina therapy; clinical outcome; coronary microvascular dysfunction; myocardial ischaemia; normal coronary arteries
Year: 2018 PMID: 30443265 PMCID: PMC6234490 DOI: 10.15420/icr.2018.15.2
Source DB: PubMed Journal: Interv Cardiol ISSN: 1756-1485